CAMP4 Appoints Michael MacLean to its Board of Directors

Stock Information for CAMP4 Therapeutics Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About CAMP4 Therapeutics Corporation

CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMP4 to Participate in Upcoming Investor Conferences
CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights
CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.